Review Article

Hypertension May Reduce the Infection Risk but Increase the Severity of COVID-19: Based on the Current Data in China

Figure 6

(a) Prevalence of usage of ACEIs/ARBs in COVID-19 patients with hypertension. (b) Comparison of mortality in ACEI/ARB and non-ACEI/ARB patients. (c) Comparison of the incidences of the severe/ICU rate in ACEI/ARB and non-ACEI/ARB patients.
(a)
(b)
(c)